190 search results for: Clinical Management

EAACI 2024 On-Treatment <b>Clinical</b> Remission in Upper and Lower Airways: Going Beyond Symptom Control
On Demand
EAACI 2024 On-Treatment Clinical Remission in Upper and Lower Airways: Going Beyond Symptom Control

Join global experts for an educational symposium on elevating treatment goals from control to remission in the upper and lower airways.

World Congress of Dermatology (WCD) 2023 | Singapore
Congress
4
July
2023
Congress
World Congress of Dermatology (WCD) 2023 | Singapore

Highlights from the ADVENT symposium at the 2023 World Congress of Dermatology in Singapore.

Digestive Disease Week 2024 | Washington D.C.
Awareness Day
18
May
2024
Awareness Day
Digestive Disease Week 2024 | Washington D.C.

Join ADVENT at the Digestive Disease Week 2024 Congress and visit the Sanofi and Regeneron Medical Booth # 1707.

Urticaria Centers of Reference and Excellence (UCARE) 2023 | São Paulo
Congress
8
December
2023
Congress
Urticaria Centers of Reference and Excellence (UCARE) 2023 | São Paulo

Exploring the role of type 2 inflammation and the neuroimmune axis in CSU, and how emerging therapeutics are targeting key molecules in these pathways.

Identification and <b>Management</b> of AD Uncontrolled With Topical Therapies in Children
Dermatology
Identification and Management of AD Uncontrolled With Topical Therapies in Children
expert video

In this expert interview video focusing on topics from the October 2024 ADVENT symposium at EAPS in Vienna, Austria, Dr Perla Lansang discusses how to identify pediatric patients with AD uncontrolled with topical therapies, considerations for the next step in care for these patients, and the potential benefits of early intervention with systemic treatment

View more
Emerging Perspectives on the Disease Burden and <b>Management</b> of Children With Atopic Dermatitis
Dermatology
Emerging Perspectives on the Disease Burden and Management of Children With Atopic Dermatitis
expert video

This video of the October 2024 ADVENT symposium at EAPS in Vienna, Austria features Drs Christine Bangert, Mark Boguniewicz, and Perla Lansang as they discuss the inflammatory processes driven by type 2 cytokines that lead to AD and atopic comorbidities, the multidimensional and cumulative disease burden associated with AD and its comorbidities, and the current and emerging treatment options for children with AD uncontrolled with topical therapy

View more
ADVENT On Air | Getting to Grips With Atopic Hand and Foot Dermatitis: What Is It, and What Does It Mean for Patients?
Dermatology
ADVENT On Air | Getting to Grips With Atopic Hand and Foot Dermatitis: What Is It, and What Does It Mean for Patients?
Podcast

This podcast episode looks at the epidemiology, clinical presentation and classification of atopic dermatitis of the hand and feet and the impact it has on patients' quality of life.

View more
Master Clinician Video | Advanced <b>Clinical</b> Practice in EoE (Full)
Gastroenterology
Master Clinician Video | Advanced Clinical Practice in EoE (Full)
videoanimation

Learn how a food bolus impaction event can help identify a patient with EoE and the importance of multiple disease domains in assessing EoE.

View more
ADVENT On Air | Best Practice for CSU - Perspectives from Allergy and Dermatology
Dermatology
ADVENT On Air | Best Practice for CSU - Perspectives from Allergy and Dermatology
Podcast

Join allergist Dr. Nicole Chase and dermatologist Dr. Jason Hawkes as they dispel common myths in the management of chronic spontaneous urticaria (CSU). They offer practical, empathetic strategies to move beyond unnecessary diagnostics and delays, focusing instead on urgent treatment escalation and effective management to reduce the profound burden of uncontrolled CSU on patients.

View more
IFOS 2023 | Type 2 Inflammation and <b>Clinical</b>ly Relevant Improvements in CRSwNP
On Demand
IFOS 2023 | Type 2 Inflammation and Clinically Relevant Improvements in CRSwNP

Dr. Stella Lee and Profs. Peter Hellings and Wytske Fokkens discuss type 2 inflammation, partnering with patients to improve outcomes, and real-world data on biologic effectiveness in CRSwNP.